Presage Biosciences
Presage Biosciences develops and offers the CIVO platform, a patented technology that delivers microdoses of multiple drugs directly into different regions of a tumor within a patient to observe molecular and cellular responses. This platform provides detailed insights into the tumor microenvironment, supporting oncology researchers and drug developers in evaluating drug candidates and combinations more effectively. Its mission is to improve cancer drug development and targeting, aiming to provide more effective treatments for patients with cancer.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology, Oncology, Life Sciences
- Founded
- 2010 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Presage Biosciences Inc Seattle business license
- Stage
- Seed
Is this your organization? Claim it
Members see Presage Biosciences's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events